These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11168343

  • 1. Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH, EURODIAB IDDM Complications Study.
    Diabet Med; 2001 Jan; 18(1):59-67. PubMed ID: 11168343
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, Fuller JH.
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group.
    Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B.
    Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621
    [Abstract] [Full Text] [Related]

  • 4. A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study.
    Lloyd CE, Stephenson J, Fuller JH, Orchard TJ.
    Diabetes Care; 1996 Mar; 19(3):219-25. PubMed ID: 8742565
    [Abstract] [Full Text] [Related]

  • 5. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N, Stephenson JM, Fuller JH.
    Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
    [Abstract] [Full Text] [Related]

  • 7. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study.
    Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R.
    Diabetologia; 1995 May; 38(5):599-603. PubMed ID: 7489844
    [Abstract] [Full Text] [Related]

  • 8. Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.
    Lutale JJ, Thordarson H, Abbas ZG, Vetvik K.
    BMC Nephrol; 2007 Jan 15; 8():2. PubMed ID: 17224056
    [Abstract] [Full Text] [Related]

  • 9. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.
    Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG.
    Arch Intern Med; 1998 Sep 28; 158(17):1933-9. PubMed ID: 9759691
    [Abstract] [Full Text] [Related]

  • 10. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S, Persson B.
    Diabetes Care; 1995 Jul 28; 18(7):933-9. PubMed ID: 7555552
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
    De Pablos PL, Martinez J, Martinez MP, Doreste JA.
    Diabetes Metab; 1998 Sep 28; 24(4):337-43. PubMed ID: 9805644
    [Abstract] [Full Text] [Related]

  • 12. [Coronary risk factors in a group of patients with insulin dependent diabetes mellitus--examination of the EURODIAB IDDM Complications Study Krakow].
    Idzior-Waluś B, Solnica B, Szopinska-Ciba L, Sieradzki J.
    Przegl Lek; 1994 Sep 28; 51(11):468-74. PubMed ID: 7871192
    [Abstract] [Full Text] [Related]

  • 13. Microalbuminuria is not rare before 5 years of IDDM. EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group.
    Stephenson JM, Fuller JH.
    J Diabetes Complications; 1994 Sep 28; 8(3):166-73. PubMed ID: 8086653
    [Abstract] [Full Text] [Related]

  • 14. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.
    Diabetologia; 1998 Jun 28; 41(6):684-93. PubMed ID: 9662051
    [Abstract] [Full Text] [Related]

  • 15. [Lipids, microalbuminuria and systemic blood pressure in patients with insulin-dependent diabetes mellitus].
    Gomes MB, Lucchetti MR, Gazzola H, Dimetz T, Lobão VI, Stum JA.
    Arq Bras Cardiol; 1997 Feb 28; 68(2):85-9. PubMed ID: 9433832
    [Abstract] [Full Text] [Related]

  • 16. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.
    Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabet Med; 2002 Nov 28; 19(11):900-9. PubMed ID: 12421426
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
    Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH, EURODIAB Prospective Complications Study Group.
    Diabetes Care; 2004 Feb 28; 27(2):530-7. PubMed ID: 14747240
    [Abstract] [Full Text] [Related]

  • 18. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ.
    Diabetes Care; 1993 Oct 28; 16(10):1376-83. PubMed ID: 8269796
    [Abstract] [Full Text] [Related]

  • 19. Microalbuminuria development in short-term IDDM.
    González-Clemente JM, Esmatjes E, Navarro P, Ercilla G, Casamitjana R, Rios M, Levy I, Gomis R, Vilardell E.
    Diabetes Res Clin Pract; 1994 May 28; 24(1):15-23. PubMed ID: 7924882
    [Abstract] [Full Text] [Related]

  • 20. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N, Stephenson JM, Fuller JH.
    Diabetes Care; 1995 Jun 28; 18(6):785-92. PubMed ID: 7555504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.